Below is a comprehensive archive of press releases from MSF USA. Use the options in the boxes below to filter results based on your preferences.

Country/Region

Topic

February 19, 2015

MSF urges all parties to the Syrian conflict to facilitate the evacuation of people wounded in recent fierce clashes in the city of Aleppo, where the population has been trapped by fighting and aerial bombardments for months.

February 18, 2015

MSF calls on Serbian authorities and EU member states to provide aid and protection.

February 04, 2015

BRUSSELS/NEW YORKA trial of the experimental Ebola drug brincidofovir in Liberia has officially ended due to a significant drop in the number of new Ebola cases and the drug manufacturer’s decision to withdraw from the trial, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières said Tuesday. 

January 28, 2015

NEW YORK—As negotiators hold closed-door meetings in Manhattan this week over a secretive trade deal that could affect the health of half a billion people, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) took its protest against the Trans-Pacific Partnership (TPP) to the skies Wednesday, flying an aerial banner that read “Doctors to Obama: Keep #TPP Away From Our Medicines” along the Hudson River.

January 28, 2015

Medical operations halted following government’s systematic denial of access.

January 26, 2015

Secret meeting this week in New York a chance to remove provisions that threaten access to lifesaving medicines.

January 23, 2015

New intellectual property "think tank" draft policy already showing alarming trend.

January 22, 2015

NEW YORK/PARIS—A hospital operated by the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) was directly targeted in an aerial bombing in Sudan on January 20, forcing the suspension of medical activities, MSF announced today.

January 20, 2015

Doctors Without Borders/Médecins Sans Frontières (MSF) today called on pharmaceutical companies GlaxoSmithKline (GSK) and Pfizer to slash the price of the pneumococcal vaccine to US$5 per child in developing countries, ahead of a major vaccination donor conference in Berlin.

January 14, 2015

The Indian Patent Controller today rejected one of Gilead’s key patent applications, which covered the drug sofosbuvir, used to treat hepatitis C (HCV). The oral drug, which first received regulatory approval in the US in November 2013, and has been priced by Gilead at US$84,000 for a treatment course, or $1,000 per pill in the US, has caused a worldwide debate on the pricing of patented medicines. A study from Liverpool University showed that sofosbuvir could be produced for as little as $101 for a three-month treatment course.

Pages